Modifying Antiretroviral Therapy in Virologically Suppressed HIV-Infected Patients
Switching From a Boosted PI to an INSTI-Based Regimen
Several trials have been undertaken to address the safety and efficacy of modifying boosted PI–based regimens to 3-drug regimens containing dolutegravir, bictegravir, raltegravir, and to ...
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content